Percutaneous saline-enhanced radiofrequency ablation of unresectable hepatic tumors:: Initial experience in 26 patients

被引:106
|
作者
Kettenbach, J
Köstler, W
Rücklinger, E
Gustorff, B
Hüpfl, M
Wolf, F
Peer, K
Weigner, M
Lammer, J
Müller, W
Goldberg, SN
机构
[1] Univ Vienna, Sch Med, Dept Diagnost Radiol, Div Angiog & Intervent Radiol, A-1090 Vienna, Austria
[2] Stat Anal Method Consulting, A-1200 Vienna, Austria
[3] Univ Vienna, Dept Anesthesiol & Intens Care B, A-1090 Vienna, Austria
[4] Univ Vienna, Sch Med, Dept Radiotherapy, A-1090 Vienna, Austria
[5] Wilhelminenspital Stadt Wien, A-1160 Vienna, Austria
[6] Univ Dept Biomed Engn, Fachhsch Furtwangen, D-78054 Villingen Schwenningen, Germany
[7] Beth Israel Deaconess Med Ctr, Dept Radiol, Harvard Med Sch, Boston, MA 02215 USA
关键词
D O I
10.2214/ajr.180.6.1801537
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Objective. The purpose of our study was to evaluate the safety and efficacy of percutaneous saline-enhanced radiofrequency ablation for unresectable primary or metastatic hepatic tumors. Subjects and Methods. Twenty-six patients with 15 hepatocellular carcinomas and 33 hepatic metastases (maximum diameter less than or equal to8.6 cm) were treated; of these, seven tumors in five patients were treated twice. Thus, 44 radiofrequency treatments were performed. Saline-enhanced and impedance-controlled radiofrequency ablation (0.5-1.1 mL/min of saline, 15-mm conductive portion of the electrode tip, 25-60 W, 5-43 min) was performed using MR imaging guidance. Coagulation necrosis, volume indexes, morbidity, and complications were assessed. Results. The volume of coagulation necrosis 1-7 days after radiofrequency ablation was 1.6-126.6 cm(3) (median, 18.9 cm(3)), corresponding to coagulation diameters of 1.5-6.2 cm (median, 3.2 cm). The coagulation volume was significantly larger if there were more than four radiofrequency applications (p=0.006). Tumors of 3 cm or less in diameter were eight times as likely to be successfully completely ablated (p=0.01) and volume indexes of lesions treated with the patient under general anesthesia were significantly larger than those treated with the patient under conscious sedation (p<0.001). Major complications occurred in four patients (15%). Incomplete ablation in 19 (35%) of 54 radiofrequency lesions was due to cooling by a large vessel nearby (n=2) or to low power applied in painful (n=11) or critical (n=6) locations. Residual tumor was observed in 14 (58%) of 24 tumors evaluated 6-8 months after radiofrequency ablation. Conclusion. Percutaneous saline-enhanced and impedance-controlled radiofrequency ablation can be effective in the treatment of unresectable hepatic tumors and minimizes potential carbonization. A greater number of radiofrequency applications, general anesthesia, and increasing experience provide significantly better results.
引用
收藏
页码:1537 / 1545
页数:9
相关论文
共 50 条
  • [21] Intermediate Oncological Outcomes of Percutaneous Radiofrequency Ablation for Small Renal Tumors: Initial Experience
    Nitta, Yujiro
    Tanaka, Tomoaki
    Morimoto, Kazuya
    Makino, Tetsuya
    Nishikawa, Noriaki
    Tashiro, Kouichiro
    Naganuma, Toshihide
    Iguchi, Taro
    Matsuoka, Toshiyuki
    Nakatani, Tatsuya
    ANTICANCER RESEARCH, 2012, 32 (02) : 615 - 618
  • [22] Premature roll-off in radiofrequency ablation using bipolar saline-enhanced electrodes - Reply
    Lee, JM
    EUROPEAN RADIOLOGY, 2005, 15 (07) : 1497 - 1498
  • [23] Excessive hyperthermic necrosis of a pulmonary lobe after hypertonic saline-enhanced monopolar radiofrequency ablation
    Kim, TS
    Lim, HK
    Kim, H
    CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 2006, 29 (01) : 160 - 163
  • [24] Bipolar saline-enhanced electrode for radiofrequency ablation:: Results of experimental study of in vivo porcine liver
    Burdío, F
    Güemes, A
    Burdío, JM
    Navarro, A
    Sousa, R
    Castiella, T
    Cruz, I
    Burzaco, O
    Lozano, R
    RADIOLOGY, 2003, 229 (02) : 447 - 456
  • [25] Radiofrequency ablation of 231 unresectable hepatic tumors: Indications, limitations, and complications
    Thomas F. Wood
    D. Michael Rose
    Mathew Chung
    David P. Allegra
    Leland J. Foshag
    Anton J. Bilchik
    Annals of Surgical Oncology, 2000, 7 : 593 - 600
  • [26] Initial experience with radiofrequency ablation for hepatic tumours in the Netherlands
    Mutsaerts, ELAR
    Van Coevorden, F
    Krause, R
    Rinkes, IHMB
    Strobbe, LJA
    Prevoo, W
    Tollenaar, RAEM
    Van Gulik, TM
    EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 2003, 29 (09): : 731 - 734
  • [27] Percutaneous radiofrequency ablation for unresectable large hepatic tumours during hepatic blood flow occlusion in four patients
    Miymoto, N
    Tsuji, K
    Sakurai, Y
    Nishimori, H
    Kang, JH
    Mitsui, S
    Maguchi, H
    CLINICAL RADIOLOGY, 2004, 59 (09) : 812 - 818
  • [28] Alleviating the pain of unresectable hepatic tumors by percutaneous cryoablation: Experience in 73 patients
    Long Xin'an
    Zeng Jianying
    Niu Lizhi
    Yao Fei
    Wang Xiaohua
    Chen Jibing
    Li Jialiang
    Xu Kecheng
    CRYOBIOLOGY, 2013, 67 (03) : 369 - 373
  • [29] Image-Guided Radiofrequency Ablation (RFA) of Unresectable Hepatic Tumors Using a Triple-Spiral-Shaped Electrode Needle: Initial Experience in 34 Patients
    Loukas Thanos
    Loukia S. Poulou
    Panayiotis D. Ziakas
    Alexis D. Kelekis
    Maria Pomoni
    Dimitrios A. Kelekis
    CardioVascular and Interventional Radiology, 2010, 33 : 107 - 112
  • [30] Image-Guided Radiofrequency Ablation (RFA) of Unresectable Hepatic Tumors Using a Triple-Spiral-Shaped Electrode Needle: Initial Experience in 34 Patients
    Thanos, Loukas
    Poulou, Loukia S.
    Ziakas, Panayiotis D.
    Kelekis, Alexis D.
    Pomoni, Maria
    Kelekis, Dimitrios A.
    CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 2010, 33 (01) : 107 - 112